{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/10/3309444/0/en/Press-Release-Sanofi-provides-update-on-MOBILIZE-phase-3-study-of-riliprubart-in-chronic-inflammatory-demyelinating-polyneuropathy.html", "message": "News view counter 790535 successfully enlarged"}